(3S)-3-((R)-4-amino-2-((S)-2-decanamido-3-(1H-indol-3-yl) propanamido) -4-oxobutanamido)-4-(((5R,8S,11S,14R,15S,21S,24S,27R,30S)-11-(2-(2-aminophenyl)-2-oxoethyl)-21-(3-aminopropyl)-24-(carboxymethyl)-8-((R)-1-carboxypropan-2-yl)-5-(hydroxymethyl)-14,27-dimethyl-3,6,9,12,16,19,22,25,28,32,33-undecaoxo-13-oxa-1,4,7,10,17,20,23,26,29-nonaazabicyclo[28.2.1]tritriacontan-15-yl)amino)-4-oxobutanoic acid Acetate Salt
Anhydro-Daptomycin Acetate Salt (90%) is a fully characterized chemical compound used as a reference standard of API Daptomycin. The standard offered is compliant with regulatory guidelines. Anhydro-Daptomycin Acetate Salt (90%) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
Daptomycin Impurity 28 (linear Daptomycin impurity, Acetate Salt)
M.F.
M.W. 1638.71; 59.04
CAT# AR-D06100
CAS# NA
Daptomycin Impurity 33 (Daptomycin beta-isomer diastereomer, Acetate Salt)
M.F. -
M.W. 1620.69; 59.04
CAT# AR-D06105
CAS# NA
